October 10, 2017 / 11:09 AM / 2 months ago

BRIEF-Recro pharma says ‍IV meloxicam 30mg demonstrates statistically significant reductions in pain

Oct 10 (Reuters) - Recro Pharma Inc:

* Recro Pharma Inc - ‍IV meloxicam 30mg demonstrates statistically significant reductions in pain, along with reductions in opioid rescue use​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below